Table 2 Univariate and multivariate analyses of prognostic factors for overall survival
Univariate | Multivariate | ||||
|---|---|---|---|---|---|
Variables | n (%) | HR (95% CI) | P value | HR (95% CI) | P value |
Age ≧ 65 years | 57 (46) | 1.47 (0.97–2.22) | 0.069 | 1.52 (0.99–2.33) | 0.053 |
Gender, Male | 65 (53) | 0.82 (0.55–1.24) | 0.351 | ||
ECOG-PS, 0 | 94 (76) | 0.93 (0.59–1.47) | 0.744 | ||
Tumor location, Body-tail | 64 (52) | 0.50 (0.33–0.76) | 0.001 | 0.12 (0.02–0.91) | 0.040 |
CEA ≧ 5 ng/mL | 34 (28) | 1.27 (0.82–1.97) | 0.291 | ||
CA19-9 ≧ 37 U/mL | 104 (85) | 0.98 (0.55–1.74) | 0.940 | ||
Pathological diagnosis, Yes | 75 (61) | 0.89 (0.59–1.35) | 0.589 | ||
Lymph node metastasis, Negative | 82 (67) | 1.04 (0.68–1.60) | 0.846 | ||
Bile duct invasion, Negative | 60 (49) | 0.61 (0.40–0.92) | 0.018 | 7.22 (0.76–68.4) | 0.085 |
Duodenal invasion, Negative | 59 (48) | 0.57 (0.38–0.87) | 0.009 | 0.55 (0.19–1.63) | 0.283 |
Anterior peripancreatic invasion, Negative | 19 (15) | 0.50 (0.27–0.92) | 0.027 | 0.46 (0.25–0.86) | 0.015 |
GTV V60GyE ≧ 60% | 59 (48) | 0.77 (0.51–1.16) | 0.208 | ||